Back to today’s briefing

Story perspectives

Ensemble Health Eyes $13B Sale or IPO by 2026

10/24/2025

49 7

Summary

Story summary

Ensemble Health is exploring a potential $13 billion sale or initial public offering in 2026, according to Business Insider.
Warburg Pincus and Berkshire Partners back Ensemble Health, and JPMorgan and Goldman Sachs lead the dual-track process.
Ensemble aims for a higher valuation than the previously reported $12 billion.
Founded in 2014, Ensemble Health provides AI-enabled software to help hospitals improve revenue collection.

1 of 1

Story summary

Ensemble Health is exploring a potential $13 billion sale or initial public offering in 2026, according to Business Insider.
Warburg Pincus and Berkshire Partners back Ensemble Health, and JPMorgan and Goldman Sachs lead the dual-track process.
Ensemble aims for a higher valuation than the previously reported $12 billion.
Founded in 2014, Ensemble Health provides AI-enabled software to help hospitals improve revenue collection.